ÍøºìºÚÁÏ

Skip to main content
(352) 265-8940

Amir M Emtiazjoo, MD, MSc

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Amir M Emtiazjoo
(352) 265-8940 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Lung Transplantation , 21 publications
  • Disease Models, Animal , 6 publications
  • Extracorporeal Membrane Oxygenation , 5 publications
  • Respiratory Insufficiency , 4 publications

Research activity

42 publications

419 citations

Why is this important?

Active clinical trials

BOSTON 3

The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.

Investigator
Amir M Emtiazjoo
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

42 publications

2019

Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.

Transplant immunology

•

2019

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.

Transplant international : official journal of the European Society for Organ Transplantation

•

2019

The Impact of Donor and Recipient Age: Older Lung Transplant Recipients Do Not Require Younger Lungs.

The Annals of thoracic surgery

•

2018

Correction: Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis.

PloS one

•

2017

A 42-Year-Old Woman With Anemia, Shock, and Ischemic Stroke After Lung Transplantation.

Chest

•